Skip to main content

Live Cytosorbents Corp. Share Price Chart

O 4.37H 4.37L 4.37

Cytosorbents Corp. Performance Overview

Days Range
▼
$4.70Low
$4.92High

Markets Today

Previous Close$4.52
Open$4.75
Volume13,909
Day's Range$4.70 - $4.92
52W RangeNA
Market Cap$14.24 M

Historical Performance

1M Returns+12.20
3M Returns-21.84
6M Returns-41.11
1Y Returns-56.44
5Y Returns-94.69
10Y Returns-94.60

Cytosorbents Corp. Fundamentals

Market Cap$14.24 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$37.06 M
ROE TTM-0.96
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-12.74 M
Profit Margin-22.12
Market Cap$14.24 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
Revenue$37.06 M
ROE TTM-0.96
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-12.74 M
Profit Margin-22.12

Cytosorbents Corp. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$8.73 M$9.62 M$9.48 M$9.23 M$8.86 M$9.63 M
Gross Profit +$6.21 M$6.81 M$6.67 M$6.80 M$6.13 M$7.05 M
Operating Income -$3.89 M-$3.62 M-$2.86 M-$4.38 M-$3.04 M-$2.64 M
EBITDA -$3.52 M-$3.21 M-$2.50 M-$3.52 M-$2.69 M-$2.02 M
Interest Expense -$605.00 K-$616.00 K$0$0-$857.00 K-$868.00 K
Depreciation $369.00 K$404.00 K$364.00 K$869.00 K$350.00 K$619.00 K
Income Before Tax -$1.48 M$1.95 M-$3.57 M-$5.50 M-$5.13 M-$4.42 M
Income Tax Expense $0$0-$401.00 K$0$0$0
Net Income +-$1.48 M$1.95 M-$3.17 M-$5.50 M-$5.13 M-$4.42 M
Net Profit Margin -16.95%20.25%-33.42%-59.53%-57.86%-45.85%

Cytosorbents Corp. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $62.53 K$63.00 K$63.00 K$63.00 K$63.00 K$63.00 K
Reserve & Surplus -$303.97 M-$307.50 M-$310.55 M-$315.18 M-$319.44 M-$322.75 M
Non-Current Liabilities $26.50 M$26.56 M$26.62 M$28.57 M$22.07 M$14.69 M
Current Liabilities $9.74 M$9.84 M$10.11 M$9.71 M$16.30 M$24.02 M
Total Liabilities $36.24 M$36.40 M$36.73 M$38.28 M$38.37 M$38.71 M
Fixed Assets $8.72 M$8.47 M$8.19 M$11.05 M$10.46 M$10.04 M
Current Assets $25.41 M$22.99 M$21.31 M$20.63 M$17.76 M$15.74 M
Total Assets $50.78 M$47.99 M$45.75 M$44.18 M$40.56 M$37.96 M

Cytosorbents Corp. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$1.48 M$1.95 M-$3.17 M-$5.50 M-$5.13 M-$4.42 M
Operating Cash Flow -$3.47 M-$1.51 M-$2.58 M-$4.83 M-$1.16 M-$583.00 K
Investing Cash Flow -$47.00 K-$132.00 K$55.00 K-$291.00 K-$46.00 K$7.00 K
Financing Cash Flow $6.83 M$0$0$2.48 M$0$0
Change in Cash $3.35 M-$1.38 M-$2.67 M-$1.29 M-$1.44 M-$400.00 K

Cytosorbents Corp. Return Calculator

The Cytosorbents Corp. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$478
Invested Amount$10,000
Est. Returns$-9,522
Invest in USA Stock Today

About Cytosorbents Corp.

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

FAQs

Cytosorbents Corp. (CTSO) share price as of November 19, 2026 is $5.01. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Cytosorbents Corp. (CTSO) Share by opening an international trading account with Angel One.
Purchasing Cytosorbents Corp. (CTSO) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Cytosorbents Corp. (CTSO) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Cytosorbents Corp. (CTSO) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Cytosorbents Corp. on November 19, 2026, is $14.24 M.
Cytosorbents Corp. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Cytosorbents Corp. (CTSO) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.